{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-24-047980","form_type":"8-K","ticker":"GYRE","cik":"0001124105","company_name":"GYRE THERAPEUTICS, INC.","filed_at":"2024-11-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:07.724485+00:00","generated_at":"2026-05-29T13:30:48.919085+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Gyre Therapeutics enters $50M at-the-market equity offering with Jefferies","bullets":["ATM agreement filed Nov 27, 2024; up to $50M of common stock may be sold.","Jefferies LLC acts as sales agent; commission up to 3.0% of gross proceeds.","Proceeds intended for R&D, manufacturing, scale-up, and general corporate purposes.","Sales may be made on Nasdaq under effective S-3 shelf registration statement."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-24-047980","json":"https://secwatch.observer/filing/0001140361-24-047980.json","markdown":"https://secwatch.observer/filing/0001140361-24-047980.md","text":"https://secwatch.observer/filing/0001140361-24-047980.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1124105/000114036124047980/0001140361-24-047980-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1124105/000114036124047980/ny20036484x4_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T13:30:48.919085+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}